Real world evidence for regulatory decision making
On-demand webinar: The Growing Regulatory Use of RWE
- IQVIA’s Dr. Nancy Dreyer sits down with FDA’s Dr. Jaqueline Corrigan-Curay for a conversation on how RWE can compliment and extend the information value from RCT’s, such as addressing the need for evaluating treatment benefits in populations that are underrepresented in RCTs
Publication: When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?
- Discover fit-for-purpose design options for extension studies, related methodological considerations, and scientific and operational guidance on practices when planning to conduct an extension study using real world data
Whitepaper: The Impact of COVID-19 on Real-World Health Data and Research
- In this whitepaper with the National Pharmaceutical Council, uncover the true impact of COVID-19 on #RWD usage and interpretation, and how to effectively leverage and understand this data as we move forward
Any questions about these resources? Want to explore how real world evidence could accelerate your business? Complete the form below to talk with us.
Copyright © 2024 IQVIA Holdings Inc. and its affiliates. All rights reserved. Privacy Statement
